{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:22:41Z","timestamp":1780078961733,"version":"3.54.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.lfs.2019.116715","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T02:24:52Z","timestamp":1564539892000},"page":"116715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling"],"prefix":"10.1016","volume":"233","author":[{"given":"Yanyan","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huirong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2019.116715_bb0005","first-page":"JCO1900500","article-title":"Advanced epithelial ovarian cancer: do more options mean greater benefits?","author":"Bouberhan","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.lfs.2019.116715_bb0010","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nrclinonc.2015.26","article-title":"A framework for a personalized surgical approach to ovarian cancer","volume":"12","author":"Nick","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.lfs.2019.116715_bb0015","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-019-0422-6","article-title":"An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity","author":"Kopper","year":"2019","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.lfs.2019.116715_bb0020","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41419-019-1415-6","article-title":"PBK, targeted by EVI1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma","volume":"10","author":"Ma","year":"2019","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.lfs.2019.116715_bb0025","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13046-019-1061-y","article-title":"TRPM7 promotes the epithelial-mesenchymal transition in ovarian cancer through the calcium-related PI3K \/ AKT oncogenic signaling","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2019.116715_bb0030","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2147\/OTT.S155425","article-title":"First-line treatment of women with advanced ovarian cancer: focus on bevacizumab","volume":"12","author":"Marchetti","year":"2019","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.lfs.2019.116715_bb0035","doi-asserted-by":"crossref","first-page":"108787","DOI":"10.1016\/j.biopha.2019.108787","article-title":"CEMIP promotes ovarian cancer development and progression via the PI3K\/AKT signaling pathway","volume":"114","author":"Shen","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.lfs.2019.116715_bb0040","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.neo.2018.12.005","article-title":"MicroRNA-503-5p inhibits the CD97-mediated JAK2\/STAT3 pathway in metastatic or paclitaxel-resistant ovarian cancer cells","volume":"21","author":"Park","year":"2019","journal-title":"Neoplasia"},{"issue":"2","key":"10.1016\/j.lfs.2019.116715_bb0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/onc.2016.197","article-title":"Elevated STAT3 expression in ovarian cancer ascites promotes invasion and metastasis: a potential therapeutic target","volume":"36","author":"Saini","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.lfs.2019.116715_bb0050","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-018-1010-1","article-title":"Genistein inhibits stemness of SKOV3 cells induced by macrophages co-cultured with ovarian cancer stem-like cells through IL-8\/STAT3 axis","volume":"38","author":"Ning","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.lfs.2019.116715_bb0055","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1158\/0008-5472.CAN-16-1115","article-title":"The STAT3-miRNA-92-Wnt signaling pathway regulates spheroid formation and malignant progression in ovarian cancer","volume":"77","author":"Chen","year":"2017","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.116715_bb0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1158\/1535-7163.11.3.1","article-title":"Signal transducer and activator of transcription 3 (STAT3) activation in prostate cancer: direct STAT3 inhibition induces apoptosis in prostate cancer lines","volume":"3","author":"Barton","year":"2004","journal-title":"Mol. Cancer Ther."},{"issue":"2","key":"10.1016\/j.lfs.2019.116715_bb0065","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10549-017-4271-z","article-title":"Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells","volume":"164","author":"Yuan","year":"2017","journal-title":"Breast Cancer Res. Treat."},{"issue":"43","key":"10.1016\/j.lfs.2019.116715_bb0070","doi-asserted-by":"crossref","first-page":"30101","DOI":"10.1074\/jbc.M114.595868","article-title":"Systematic analysis of bacterial effector-postsynaptic density 95\/disc large\/zonula occludens-1 (PDZ) domain interactions demonstrates Shigella OspE protein promotes protein kinase C activation via PDLIM proteins","volume":"289","author":"Yi","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"30","key":"10.1016\/j.lfs.2019.116715_bb0075","doi-asserted-by":"crossref","first-page":"26849","DOI":"10.1074\/jbc.M111.241554","article-title":"Actin cytoskeleton remodeling by the alternatively spliced isoform of PDLIM4\/RIL protein","volume":"286","author":"Guryanova","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.lfs.2019.116715_bb0080","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1158\/0008-5472.CAN-06-3093","article-title":"RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis","volume":"67","author":"Boumber","year":"2007","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.lfs.2019.116715_bb0085","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/1078-0432.CCR-05-2072","article-title":"PDLIM4 repression by hypermethylation as a potential biomarker for prostate cancer","volume":"12","author":"Vanaja","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.lfs.2019.116715_bb0090","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1080\/07357900802406319","article-title":"PDLIM4, an actin binding protein, suppresses prostate cancer cell growth","volume":"27","author":"Vanaja","year":"2009","journal-title":"Cancer Investig."},{"issue":"4","key":"10.1016\/j.lfs.2019.116715_bb0095","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.lfs.2019.116715_bb0100","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13046-019-1133-z","article-title":"Sequence-dependent synergistic cytotoxicity of icotinib and pemetrexed in human lung cancer cell lines in vitro and in vivo","volume":"38","author":"Liu","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.lfs.2019.116715_bb0105","doi-asserted-by":"crossref","first-page":"10965","DOI":"10.1038\/s41598-017-11233-w","article-title":"Stat3 as a potential therapeutic target for rheumatoid arthritis","volume":"7","author":"Oike","year":"2017","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.lfs.2019.116715_bb0110","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1083\/jcb.200810155","article-title":"Reversion-induced LIM interaction with Src reveals a novel Src inactivation cycle","volume":"184","author":"Zhang","year":"2009","journal-title":"J. Cell Biol."},{"issue":"5","key":"10.1016\/j.lfs.2019.116715_bb0115","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1158\/1535-7163.MCT-14-0911","article-title":"Frequent loss of NISCH promotes tumor proliferation and invasion in ovarian cancer via inhibiting the FAK signal pathway","volume":"14","author":"Li","year":"2015","journal-title":"Mol. Cancer Ther."},{"issue":"6","key":"10.1016\/j.lfs.2019.116715_bb0120","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3892\/or.2017.5583","article-title":"CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways","volume":"37","author":"Nakamura","year":"2017","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.lfs.2019.116715_bb0125","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1158\/1535-7163.MCT-14-0800","article-title":"Targeted blockade of JAK\/STAT3 signaling inhibits ovarian carcinoma growth","volume":"14","author":"Gritsina","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.lfs.2019.116715_bb0130","doi-asserted-by":"crossref","DOI":"10.3233\/CBM-182265","article-title":"Methylation of tumour suppressor genes associated with thyroid cancer","author":"Botezatu","year":"2019","journal-title":"Cancer Biomark."},{"issue":"14","key":"10.1016\/j.lfs.2019.116715_bb0135","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1038\/onc.2009.493","article-title":"Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma","volume":"29","author":"Morris","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.lfs.2019.116715_bb0140","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/1471-2407-10-378","article-title":"Tumor suppressor genes are frequently methylated in lymph node metastases of breast cancers","volume":"10","author":"Feng","year":"2010","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.lfs.2019.116715_bb0145","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/s41467-019-08574-7","article-title":"Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer","volume":"10","author":"Li","year":"2019","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.lfs.2019.116715_bb0150","doi-asserted-by":"crossref","first-page":"7362","DOI":"10.1074\/jbc.C115.637918","article-title":"Oncovirus Kaposi sarcoma herpesvirus (KSHV) represses tumor suppressor PDLIM2 to persistently activate nuclear factor \u03baB (NF-\u03baB) and STAT3 transcription factors for tumorigenesis and tumor maintenance","volume":"290","author":"Sun","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"202","key":"10.1016\/j.lfs.2019.116715_bb0155","doi-asserted-by":"crossref","first-page":"ra85","DOI":"10.1126\/scisignal.2001637","article-title":"PDLIM2 inhibits T helper 17 cell development and granulomatous inflammation through degradation of STAT3","volume":"4","author":"Tanaka","year":"2011","journal-title":"Sci. Signal."},{"issue":"2","key":"10.1016\/j.lfs.2019.116715_bb0160","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3390\/cancers6020897","article-title":"STAT3 target genes relevant to human cancers","volume":"6","author":"Carpenter","year":"2014","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.lfs.2019.116715_bb0165","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12032-016-0786-0","article-title":"Epac1 knockdown inhibits the proliferation of ovarian cancer cells by inactivating AKT\/Cyclin D1\/CDK4 pathway in vitro and in vivo","volume":"33","author":"Gao","year":"2016","journal-title":"Med. Oncol."},{"issue":"9","key":"10.1016\/j.lfs.2019.116715_bb0170","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.1002\/jcb.27158","article-title":"The lncRNA TP73-AS1 promotes ovarian cancer cell proliferation and metastasis via modulation of MMP2 and MMP9","volume":"119","author":"Wang","year":"2018","journal-title":"J. Cell. Biochem."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519306423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320519306423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:28:56Z","timestamp":1758400136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320519306423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":34,"alternative-id":["S0024320519306423"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116715","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PDZ and LIM domain protein 4 suppresses the growth and invasion of ovarian cancer cells via inactivation of STAT3 signaling","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2019.116715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116715"}}